Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

STARTNEW MEDICAL P.C

NPI: 1346655248 · WAPPINGERS FALLS, NY 12590 · Pain Medicine (Physical Medicine & Rehabilitation) Physician · NPI assigned 06/30/2014

$559K
Total Medicaid Paid
6,145
Total Claims
5,135
Beneficiaries
12
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSPENCE, CHRISTINE (GENERAL MANAGER)
NPI Enumeration Date06/30/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,567 $124K
2019 1,578 $142K
2020 852 $63K
2021 701 $77K
2022 618 $65K
2023 510 $55K
2024 319 $33K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,228 2,949 $325K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 396 378 $62K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 212 200 $50K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 738 678 $48K
20553 495 294 $28K
76942 154 93 $19K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 226 84 $17K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 547 321 $5K
95911 15 12 $2K
95886 15 12 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 39 39 $2K
80305 80 75 $351.56